ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DOCS Dr. Martens Plc

71.65
2.90 (4.22%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dr. Martens Plc LSE:DOCS London Ordinary Share GB00BL6NGV24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.90 4.22% 71.65 70.55 71.00 71.95 69.05 70.00 3,315,666 16:35:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Footwear-wholesale 877.1M 69.2M 0.0719 25.31 661.36M

Dr. Martens PLC Director/PDMR Shareholding

14/06/2024 12:51pm

RNS Regulatory News


RNS Number : 5480S
Dr. Martens PLC
14 June 2024
 

Dr. Martens plc (the "Company")

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that on 14 June 2024 the following director / person discharging managerial responsibility ('PDMR') was granted a Performance Share Award (the "Award") under the Company's Long Term Incentive Plan (the 'LTIP').

 

PDMR

Number of Shares

Giles Wilson

1,254,310

 

The Award was made to compensate Giles for loss of long-term incentive schemes forfeited on leaving his previous employer which he would otherwise have been eligible to receive. The measures, targets and weightings are aligned to the annual LTIP award also made and announced by the Company today, 14 June 2024, and will vest subject to the achievement of earnings per share (50% weighting), relative total shareholder return (25% weighting), and operating cash flow conversion (25% weighting) targets over three years and, on vesting, will be subject to a further two-year holding period.

No consideration was paid for the grant of the Award and no price is payable on the exercise of the Award.

Full details of the target ranges will be set out in the Directors' Remuneration Report contained within the 2025 Annual Report & Accounts.

The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Giles Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Grant of performance share award under the
Dr. Martens plc Long-term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

1,254,310

d)

Aggregated information

-

Aggregated volume

-

Price

 

1,254,310

Nil

e)

Date of the transaction

2024-06-14

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSSARSKUNAAR

1 Year Dr. Martens Chart

1 Year Dr. Martens Chart

1 Month Dr. Martens Chart

1 Month Dr. Martens Chart